regeneron pharmaceuticals semaglutide announced on January 30, 2026, that its experimental obesity drug candidate delivers significant cholesterol-lowering benefits on top of weight loss—a differentiation strategy aimed at competing with Eli Lilly's and Novo Regeneron (REGN) Highlights Benefits of
Description
GLP-1s are shaking up the playbook and giving pharma companies a whole new set of moves to master
By slowing digestion and promoting a feeling of fullness, semaglutide helps individuals consume fewer calories without feeling deprived
Get these 4 ways to lower cortisol and reduce belly fat
Beyond their impact on weight, these medications have shown promise in ameliorating obesity-related health markers, including lowering blood pressure, improving lipid profiles, and enhancing glycemic control (Marso et al., 2016)
Helps Reduce Cravings and Appetite: Supports lower hunger levels, reduced snacking, and more balanced eating patterns
Clinic Secret approved me fastbut then denied me after purchase
